Literature DB >> 17353163

IL-27 induces the production of IgG1 by human B cells.

Amel Boumendjel1, Lina Tawk, René de Waal Malefijt, Vera Boulay, Hans Yssel, Jérôme Pène.   

Abstract

It has been reported that IL-27 specifically induces the production of IgG2a by mouse B cells and inhibits IL-4-induced IgG1 synthesis. Here, we show that human naïve cord blood expresses a functional IL-27 receptor, consisting of the TCCR and gp130 subunits, although at lower levels as compared to naïve and memory splenic B cells. IL-27 does not induce proliferative responses and does not increase IgG1 production by CD19(+)CD27(+) memory B cells. However, it induces a low, but significant production of IgG1 by naïve CD19(+)CD27(-)IgD(+)IgG(-) spleen and cord blood B cells, activated via CD40, whereas it has no effect on the production of the other IgG subclasses. In addition, IL-27 induces the differentiation of a population of B cells that express high levels of CD38, in association with a down-regulation of surface IgD expression, and that are surface IgG(+/int), CD20(low), CD27(high), indicating that IL-27 promotes isotype switching and plasma cell differentiation of naive B cells. However, as compared to the effects of IL-21 and IL-10, both switch factors for human IgG1 and IgG3, those of IL-27 are modest and regulate exclusively the production of IgG1. Finally, although IL-27 has no effect on IL-4 and anti-CD40-induced Cepsilon germline promoter activity, it up-regulates IL-4-induced IgE production by naive B cells. These results point to a partial redundancy of switch factors regulating the production of IgG1 in humans, and furthermore indicate the existence of a common regulation of the human IgG1and murine IgG2a isotypes by IL-27.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17353163

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  14 in total

1.  Interleukin-27 promotes CD8+ T cell reconstitution following antibody-mediated lymphoablation.

Authors:  Katayoun Ayasoufi; Daniel B Zwick; Ran Fan; Suheyla Hasgur; Michael Nicosia; Victoria Gorbacheva; Karen S Keslar; Booki Min; Robert L Fairchild; Anna Valujskikh
Journal:  JCI Insight       Date:  2019-04-04

2.  Thyroglobulin autoantibodies switch to immunoglobulin (Ig)G1 and IgG3 subclasses and preserve their restricted epitope pattern after 131I treatment for Graves' hyperthyroidism: the activity of autoimmune disease influences subclass distribution but not epitope pattern of autoantibodies.

Authors:  F Latrofa; D Ricci; L Montanelli; P Piaggi; B Mazzi; F Bianchi; F Brozzi; P Santini; E Fiore; M Marinò; M Tonacchera; P Vitti
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

Review 3.  gp130 at the nexus of inflammation, autoimmunity, and cancer.

Authors:  J S Silver; C A Hunter
Journal:  J Leukoc Biol       Date:  2010-07-07       Impact factor: 4.962

Review 4.  New directions in the basic and translational biology of interleukin-27.

Authors:  Elia D Tait Wojno; Christopher A Hunter
Journal:  Trends Immunol       Date:  2011-12-15       Impact factor: 16.687

Review 5.  Interleukin-27: balancing protective and pathological immunity.

Authors:  Christopher A Hunter; Rob Kastelein
Journal:  Immunity       Date:  2012-12-14       Impact factor: 31.745

Review 6.  IL-27-induced modulation of autoimmunity and its therapeutic potential.

Authors:  Rakeshchandra R Meka; Shivaprasad H Venkatesha; Steven Dudics; Bodhraj Acharya; Kamal D Moudgil
Journal:  Autoimmun Rev       Date:  2015-08-05       Impact factor: 9.754

7.  IL4 gene polymorphism and previous malaria experiences manipulate anti-Plasmodium falciparum antibody isotype profiles in complicated and uncomplicated malaria.

Authors:  Piyatida Tangteerawatana; Hedvig Perlmann; Masashi Hayano; Thareerat Kalambaheti; Marita Troye-Blomberg; Srisin Khusmith
Journal:  Malar J       Date:  2009-12-10       Impact factor: 2.979

8.  IL-27 in human secondary lymphoid organs attracts myeloid dendritic cells and impairs HLA class I-restricted antigen presentation.

Authors:  Fabio Morandi; Emma Di Carlo; Soldano Ferrone; Andrea Petretto; Vito Pistoia; Irma Airoldi
Journal:  J Immunol       Date:  2014-02-19       Impact factor: 5.422

9.  IgG Subclass Analysis in Patients with Chagas Disease 4 Years After Benznidazole Treatment.

Authors:  Maurício Llaguno; Marcos Vinícius da Silva; Fernanda Rodrigues Helmo; Lara Rocha Batista; Djalma Alexandre Alves da Silva; Rodrigo Cunha de Sousa; Luiz Antonio Pertili Rodrigues de Resende; Eliane Lages-Silva; Carlo José Freire Oliveira; Juliana Reis Machado; Denise Bertulucci Rocha Rodrigues; Dalmo Correia; Virmondes Rodrigues
Journal:  Acta Parasitol       Date:  2021-06-11       Impact factor: 1.440

Review 10.  Interleukin-27 and Its Diverse Effects on Bacterial Infections.

Authors:  Yugo Morita; Elysia A Masters; Edward M Schwarz; Gowrishankar Muthukrishnan
Journal:  Front Immunol       Date:  2021-05-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.